Rachel K. King

CIK 1589712 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 9, 2014 · Latest: Feb. 6, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 50 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

50 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 19, 2021 NVAX P 700 $139.64 $97,748 2,800 Direct +33.33% Acquired -93.7% (price as of 2026-08-21)
Dec. 28, 2020 CBIO S 10b5-1 84,176 $3.91 $329,128 356,064 Direct -19.12% Disposed -95.8% (price as of 2026-08-21)
March 27, 2019 NVAX P 42,000 $0.53 $22,260 42,000 Direct — Acquired -16.6% (price as of 2026-08-21)
March 27, 2019 NVAX P 22,000 $0.53 $11,660 22,000 Indirect — Acquired -16.6% (price as of 2026-08-21)
March 27, 2019 NVAX P 22,000 $0.53 $11,660 22,000 Indirect — Acquired -16.6% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 30, 2026 FULC Stock Option (right to buy) Common Stock (32,000) $3.66 June 29, 2036 32,000 Acquired
June 20, 2026 NVAX Restricted Stock Units Common Stock (18,880) — — 18,880 Disposed
June 18, 2026 NVAX Restricted Stock Units Common Stock (14,180) — — 14,180 Acquired
June 18, 2026 NVAX Stock Option (Right to Buy) Common Stock (21,270) $9.13 June 18, 2036 21,270 Acquired
June 26, 2025 FULC Stock Option (right to buy) Common Stock (36,000) $7.38 June 25, 2035 36,000 Acquired
June 20, 2025 NVAX Restricted Stock Units Common Stock (18,884) — — 18,884 Acquired
June 20, 2025 NVAX Stock Option (Right to Buy) Common Stock (28,326) $6.42 June 20, 2035 28,326 Acquired
Nov. 12, 2024 FULC Stock Option (right to buy) Common Stock (60,000) $3.64 Nov. 11, 2034 60,000 Acquired
May 1, 2024 CBIO Stock Option (right to buy) Common Stock (40,000) $1.62 April 30, 2034 40,000 Acquired
June 12, 2023 NVAX Restricted Stock Units Common Stock (6,670) — — 6,670 Acquired
June 12, 2023 NVAX Stock Option (Right to Buy) Common Stock (7,710) $7.78 June 12, 2033 7,710 Acquired
June 10, 2023 NVAX Restricted Stock Units Common Stock (3,100) — — 3,100 Disposed
May 19, 2023 CBIO Stock Option (right to buy) Common Stock (35,000) $1.98 May 18, 2033 35,000 Acquired
June 17, 2022 NVAX Restricted Stock Units Common Stock (700) — — 700 Disposed
June 10, 2022 NVAX Restricted Stock Units Common Stock (3,100) — — 3,100 Acquired
June 10, 2022 NVAX Stock Option (Right to Buy) Common Stock (4,600) $40.62 June 10, 2032 4,600 Acquired
May 18, 2022 CBIO Stock Option (right to buy) Common Stock (21,000) $0.60 May 17, 2032 21,000 Acquired
June 25, 2021 NVAX Restricted Stock Units Common Stock — — 3,450 Disposed
June 25, 2021 NVAX Restricted Stock Units Common Stock (6,900) — — 6,900 Disposed
June 17, 2021 NVAX Restricted Stock Units Common Stock (700) — — 700 Acquired
June 17, 2021 NVAX Stock Option (Right to Buy) Common Stock (1,300) $179.89 June 17, 2031 1,300 Acquired
Jan. 20, 2021 CBIO Employee Stock Option (right to buy) Common Stock (192,500) $3.81 Jan. 19, 2031 192,500 Acquired
Dec. 28, 2020 CBIO Employee Stock Option (right to buy) Common Stock (130,821) $1.12 Jan. 4, 2021 130,821 Disposed
June 25, 2020 NVAX Restricted Stock Units Common Stock (3,450) — — 3,450 Acquired
June 25, 2020 NVAX Stock Option (Right to buy) Common Stock (6,900) $83.54 June 25, 2030 6,900 Acquired
Jan. 22, 2020 CBIO Employee Stock Option (right to buy) Common Stock (349,000) $4.72 Jan. 21, 2030 349,000 Acquired
Dec. 12, 2019 NVAX Stock Option (Right to buy) Common Stock (18,000) $3.99 Dec. 12, 2029 18,000 Acquired
Aug. 6, 2019 CBIO Employee Stock Option (right to buy) Common Stock (166,759) $1.12 Jan. 4, 2021 166,759 Disposed
Jan. 17, 2019 CBIO Employee Stock Option (right to buy) Common Stock (265,000) $10.59 Jan. 16, 2029 265,000 Acquired
Oct. 31, 2018 NVAX Stock Option (Right to buy) Common Stock (160,000) $1.76 Oct. 31, 2028 160,000 Acquired
Jan. 10, 2018 CBIO Employee Stock Option (right to buy) Common Stock (175,000) $20.03 Jan. 9, 2028 175,000 Acquired
Jan. 4, 2017 CBIO Employee Stock Option (right to buy) Common Stock (175,000) $6.33 Jan. 3, 2027 175,000 Acquired
Jan. 7, 2016 CBIO Employee Stock Option (right to buy) Common Stock (141,000) $5.22 Jan. 6, 2026 141,000 Acquired
Feb. 24, 2015 CBIO Employee Stock Option (right to buy) Common Stock (50,000) $1.12 Jan. 4, 2021 50,000 Disposed
Jan. 8, 2015 CBIO Employee Stock Option (right to buy) Common Stock (141,000) $7.15 Jan. 7, 2025 141,000 Acquired
June 18, 2014 CBIO Employee Stock Option (right to buy) Common Stock (100,000) $1.12 Jan. 4, 2021 100,000 Disposed
Jan. 9, 2014 CBIO Stock Option (right to buy) Common Stock (375,639) $8.00 Jan. 9, 2024 375,639 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 9, 2014 CBIO Common Stock 8,706 Direct
Jan. 9, 2014 CBIO Common Stock 157,355 Indirect
Jan. 9, 2014 CBIO Common Stock 1,741 Indirect
Jan. 9, 2014 CBIO Employee Stock Option (right to buy)→ Common Stock — Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CBIO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2014 $417,005 — — — $156,713 — — $2,876,385

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.